Search results
Sep 15, 2022 · About 230 million Americans are eligible for a bivalent COVID-19 vaccine booster. Pfizer's bivalent booster is authorized for those 5 or older, while Moderna’s authorization is for patients 6 and up. Patients must complete a primary COVID-19 vaccine series before getting the booster.
Oct 13, 2022 · Pfizer released its first human data results on the bivalent omicron booster, which showed an increase in antibodies, but more data is needed to show how effective the shot is.
Aug 31, 2022 · Individuals 18 years of age and older are eligible for a single booster dose of the Moderna COVID-19 Vaccine, Bivalent if it has been at least two months since they have completed primary...
Sep 16, 2022 · The superiority of the antibody response against omicron after a second booster dose of 50-μg mRNA-1273.214 as compared with 50-μg mRNA-1273 was tested only after the meeting of noninferiority...
Oct 3, 2022 · While the BQ and XBB variant families, which took hold in the U.S. in late 2022, are more immune-evasive than the original omicron strain, the bivalent booster still appears to be effective in reducing the risk of severe disease. If you’re eligible to receive the bivalent booster, get it.
Oct 12, 2022 · COVID-19. Questions answered about the COVID-19 bivalent booster vaccines. Deb Balzer. October 12, 2022. The Centers for Disease Control and Prevention (CDC) encourages those eligible to receive the new bivalent COVID-19 booster vaccine.
May 3, 2023 · Bivalent Boosters against Severe Omicron Infection. Published May 3, 2023. N Engl J Med 2023;388: 1726 - 1727. DOI: 10.1056/NEJMc2303753. VOL. 388 NO. 18. To the Editor: Lin and colleagues...
